Novartis (NVS)
(Delayed Data from NYSE)
$102.76 USD
-0.37 (-0.36%)
Updated Jun 3, 2024 04:00 PM ET
After-Market: $102.78 +0.02 (0.02%) 5:52 PM ET
3-Hold of 5 3
B Value C Growth C Momentum C VGM
Brokerage Reports
Novartis AG [NVS]
Reports for Purchase
Showing records 421 - 440 ( 475 total )
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Highlights and Key Takeaways from ID Week 2015
Provider: H.C. Wainwright & Co., Inc.
Analyst: BREIDENBACH M
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Oct 3
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Biotechnology/Biopharmaceuticals/BioDefense-Recent Drug Launch Weekly Retail Sales Tracker - Week Ended Sept 12
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker- Week Ended August 29
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Novartis AG
Industry: Large Cap Pharmaceuticals
Recent Drug Launch Weekly Retail Sales Tracker - Week Ended August 22
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D